These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7680853)

  • 1. Topical use of aprotinin in open heart operations.
    Tatar H; Ciçek S; Demirkiliç U; Ozal E; Süer H; Oztürk O; Işiklar H
    Ann Thorac Surg; 1993 Mar; 55(3):659-61. PubMed ID: 7680853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical use of aprotinin in coronary artery bypass surgery.
    Mand'ák J; Lonský V; Dominik J
    Acta Medica (Hradec Kralove); 1999; 42(4):139-44. PubMed ID: 10812681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
    Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
    Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical application of aprotinin in cardiac surgery.
    Isgro F; Stanisch O; Kiessling AH; Gürler S; Hellstern P; Saggau W
    Perfusion; 2002 Sep; 17(5):347-51. PubMed ID: 12243438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical aprotinin in cardiac operations.
    O'Regan DJ; Giannopoulos N; Mediratta N; Kendall SW; Forni A; Pillai R; Westaby S
    Ann Thorac Surg; 1994 Sep; 58(3):778-81. PubMed ID: 7524457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mini-dose pump-prime aprotinin inhibited enhanced fibrinolytic activity and reduced blood loss and transfusion requirements after coronary artery bypass surgery.
    Kunt AS; Darcin OT; Aydin S; Demir D; Selli C; Andac MH
    J Thromb Thrombolysis; 2005 Jun; 19(3):197-200. PubMed ID: 16082607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
    Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
    Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose aprotinin in cardiac operations.
    Haddad R; Kesrouani C; Nasr W
    J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations.
    Misfeld M; Dubbert S; Eleftheriadis S; Siemens HJ; Wagner T; Sievers HH
    Ann Thorac Surg; 1998 Sep; 66(3):792-9. PubMed ID: 9768932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use.
    Ciçek S; Demirkiliç U; Ozal E; Kuralay E; Bingol H; Tatar H; Ozturk OY
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1462-7. PubMed ID: 8975837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency.
    Bidstrup BP; Underwood SR; Sapsford RN; Streets EM
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):147-52; discussion 153. PubMed ID: 7678314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients.
    Hardy JF; Desroches J; Belisle S; Perrault J; Carrier M; Robitaille D
    Can J Anaesth; 1993 Jul; 40(7):625-31. PubMed ID: 7691426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical aprotinin on early postoperative bleeding and ICU stay after coronary artery bypass graft surgeries.
    Mehraien A; Ghafari A; Mohammadi SS
    Pak J Biol Sci; 2009 May; 12(10):813-6. PubMed ID: 19806814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study.
    Bedirhan MA; Turna A; Yagan N; Taşçi O
    Eur J Cardiothorac Surg; 2001 Dec; 20(6):1122-7. PubMed ID: 11717015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
    Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
    Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.